Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178750 | SCV000230896 | uncertain significance | not provided | 2016-04-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001852222 | SCV002308930 | uncertain significance | Peroxisome biogenesis disorder | 2022-07-27 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 438 of the PEX6 protein (p.Leu438Pro). This variant is present in population databases (rs778025463, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of peroxisomal biogenesis disorders (Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 197656). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |